Heng‐Huan Lee - Concepedia

Author

Heng‐Huan Lee

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Heng-Huan Huan Lee, Heng-Huan Lee, Heng‐Huan Lee

124

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center China Medical University The University of Texas Health Science Center at Houston Asia University China Medical University Hospital

About

Heng‐Huan Lee is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	24	4.2K
2	Cell Biology	19	21	3.7K
3	Cellular Physiology	3	3	317
4	Natural Sciences	2	2	145
5	Engineering	1	1	11

Heng‐Huan Lee

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity Chia‐Wei Li, Seung-Oe Lim, Weiya Xia, Nature Communications	2016	1.1K
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression Shiping Jiao, Weiya Xia, Hirohito Yamaguchi, Clinical Cancer Research	2017	943
p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs Chun-Ju Chang, Chi-Hong Chao, Weiya Xia, Nature Cell Biology Developmental BiologyStem Cell PropertiesEpigenetic RegulationMedicineEpithelial–mesenchymal Transition	2011	752
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1 Jong‐Ho Cha, Wenhao Yang, Weiya Xia, Molecular Cell MedicineEndoplasmic-reticulum-associated DegradationApoptosisImmunologyTumor Immunity	2018	732
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1 Chia‐Wei Li, Seung-Oe Lim, Ezra M. Chung, Cancer Cell Breast OncologyMedicineImmunologyImmune Checkpoint InhibitorBreast Cancer	2018	590
Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy Heng‐Huan Lee, Ying‐Nai Wang, Weiya Xia, Cancer Cell MedicineImmunologyGlycobiologyPharmacotherapyCarbohydrate-protein Interaction	2019	387
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion Li-Chuan Chan, Chia‐Wei Li, Weiya Xia, Journal of Clinical Investigation ImmunologyImmune RegulationPathologyCell DeathPd-l1 Y112 Phosphorylation	2019	364
TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis Zhou Jiang, Seung-Oe Lim, Meisi Yan, Journal of Clinical Investigation	2021	300
EGFR Signaling Enhances Aerobic Glycolysis in Triple-Negative Breast Cancer Cells to Promote Tumor Growth and Immune Escape Seung-Oe Lim, Chia‐Wei Li, Weiya Xia, Cancer Research Breast OncologyImmunologyMetabolic RemodelingCancer BiologyTumor Biology	2016	262
Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity Linlin Sun, Chia-Wei Li, Ezra M. Chung, Cancer Research Cancer ImmunosurveillanceLigand Pd-l1Pd-l1/pd-1 BindingPd-1 GlycosylationT-regulatory Cell	2020	168

Page 1